KINE-501E

N/A

Report date: 2024/09/26 15:10:55
NME

Base Information

Drug NameKINE-501E
Drug Alias NameKINE-501E
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynuclein alpha modulators
TargetsSynuclein alpha
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKine Sciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKine Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A